Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.

The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody respon...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marion Avril, Marianne J Hathaway, Anand Srivastava, Sébastien Dechavanne, Mirja Hommel, James G Beeson, Joseph D Smith, Benoît Gamain
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/34488d96197a41ceb3b5616c494c6798
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:34488d96197a41ceb3b5616c494c6798
record_format dspace
spelling oai:doaj.org-article:34488d96197a41ceb3b5616c494c67982021-11-18T06:59:10ZAntibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.1932-620310.1371/journal.pone.0016622https://doaj.org/article/34488d96197a41ceb3b5616c494c67982011-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21326877/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody responses against most single-domain VAR2CSA immunogens. Recent advances in expression of the full-length recombinant protein showed it binds with much greater specificity and affinity to chondroitin sulphate A (CSA) than individual VAR2CSA domains. This raises the possibility that a specific CSA binding pocket(s) is formed in the full length antigen and could be an important target for vaccine development. In this study, we compared the immunogenicity of a full-length VAR2CSA recombinant protein containing all six Duffy binding-like (DBL) domains to that of a three-domain construct (DBL4-6) in mice and rabbits. Animals immunized with either immunogen acquired antibodies reacting with several VAR2CSA individual domains by ELISA, but antibody responses against the highly conserved DBL4 domain were weaker in animals immunized with full-length DBL1-6 recombinant protein compared to DBL4-6 recombinant protein. Both immunogens induced cross-reactive antibodies to several heterologous CSA-binding parasite lines expressing different VAR2CSA orthologues. However, antibodies that inhibited adhesion of parasites to CSA were only elicited in rabbits immunized with full-length immunogen and inhibition was restricted to the homologous CSA-binding parasite. These findings demonstrate that partial and full-length VAR2CSA immunogens induce cross-reactive antibodies, but inhibitory antibody responses to full-length immunogen were highly allele-specific and variable between animal species.Marion AvrilMarianne J HathawayAnand SrivastavaSébastien DechavanneMirja HommelJames G BeesonJoseph D SmithBenoît GamainPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 2, p e16622 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marion Avril
Marianne J Hathaway
Anand Srivastava
Sébastien Dechavanne
Mirja Hommel
James G Beeson
Joseph D Smith
Benoît Gamain
Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
description The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody responses against most single-domain VAR2CSA immunogens. Recent advances in expression of the full-length recombinant protein showed it binds with much greater specificity and affinity to chondroitin sulphate A (CSA) than individual VAR2CSA domains. This raises the possibility that a specific CSA binding pocket(s) is formed in the full length antigen and could be an important target for vaccine development. In this study, we compared the immunogenicity of a full-length VAR2CSA recombinant protein containing all six Duffy binding-like (DBL) domains to that of a three-domain construct (DBL4-6) in mice and rabbits. Animals immunized with either immunogen acquired antibodies reacting with several VAR2CSA individual domains by ELISA, but antibody responses against the highly conserved DBL4 domain were weaker in animals immunized with full-length DBL1-6 recombinant protein compared to DBL4-6 recombinant protein. Both immunogens induced cross-reactive antibodies to several heterologous CSA-binding parasite lines expressing different VAR2CSA orthologues. However, antibodies that inhibited adhesion of parasites to CSA were only elicited in rabbits immunized with full-length immunogen and inhibition was restricted to the homologous CSA-binding parasite. These findings demonstrate that partial and full-length VAR2CSA immunogens induce cross-reactive antibodies, but inhibitory antibody responses to full-length immunogen were highly allele-specific and variable between animal species.
format article
author Marion Avril
Marianne J Hathaway
Anand Srivastava
Sébastien Dechavanne
Mirja Hommel
James G Beeson
Joseph D Smith
Benoît Gamain
author_facet Marion Avril
Marianne J Hathaway
Anand Srivastava
Sébastien Dechavanne
Mirja Hommel
James G Beeson
Joseph D Smith
Benoît Gamain
author_sort Marion Avril
title Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
title_short Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
title_full Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
title_fullStr Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
title_full_unstemmed Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
title_sort antibodies to a full-length var2csa immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/34488d96197a41ceb3b5616c494c6798
work_keys_str_mv AT marionavril antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT mariannejhathaway antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT anandsrivastava antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT sebastiendechavanne antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT mirjahommel antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT jamesgbeeson antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT josephdsmith antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
AT benoitgamain antibodiestoafulllengthvar2csaimmunogenarebroadlystraintranscendentbutdonotcrossinhibitdifferentplacentaltypeparasiteisolates
_version_ 1718424094124277760